NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
This Quarter Return
-7.32%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.93B
AUM Growth
+$1.93B
Cap. Flow
-$89.8M
Cap. Flow %
-4.64%
Top 10 Hldgs %
70.83%
Holding
57
New
3
Increased
7
Reduced
11
Closed
8

Top Buys

1
BSX icon
Boston Scientific
BSX
$150M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
$16M
3
PHVS icon
Pharvaris
PHVS
$5.46M
4
FOLD icon
Amicus Therapeutics
FOLD
$5.37M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$4.57M

Top Sells

1
HRMY icon
Harmony Biosciences
HRMY
$53M
2
INGN icon
Inogen
INGN
$43.1M
3
MORF
Morphic Holding, Inc. Common Stock
MORF
$33.7M
4
INZY
Inozyme Pharma
INZY
$31.8M
5
PTGX icon
Protagonist Therapeutics
PTGX
$26.9M

Sector Composition

1 Healthcare 57.28%
2 Financials 8.56%
3 Technology 7.59%
4 Consumer Discretionary 1.65%
5 Communication Services 1.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$526B
$429M 22.21%
1,933,900
– –
BN icon
2
Brookfield
BN
$98.3B
$166M 8.56%
3,093,171
+18,092
+0.6% +$968K
BSX icon
3
Boston Scientific
BSX
$156B
$150M 7.77%
+3,463,577
New +$150M
AAPL icon
4
Apple
AAPL
$3.45T
$147M 7.59%
1,037,404
– –
MORF
5
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$116M 6.01%
2,050,446
-595,000
-22% -$33.7M
EWTX icon
6
Edgewise Therapeutics
EWTX
$1.51B
$92.7M 4.8%
5,587,207
– –
CYT
7
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$84.9M 4.39%
4,840,413
– –
NKTX icon
8
Nkarta
NKTX
$151M
$77.7M 4.02%
2,793,864
– –
BOLT icon
9
Bolt Biotherapeutics
BOLT
$9.85M
$57M 2.95%
4,503,991
– –
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$3.71B
$48.7M 2.52%
2,445,147
– –
INGN icon
11
Inogen
INGN
$216M
$46.5M 2.41%
1,079,320
-1,000,000
-48% -$43.1M
ALGS icon
12
Aligos Therapeutics
ALGS
$73.3M
$40.6M 2.1%
2,614,563
– –
BABA icon
13
Alibaba
BABA
$322B
$31.8M 1.65%
214,827
– –
CABO icon
14
Cable One
CABO
$909M
$28.8M 1.49%
15,873
-10,025
-39% -$18.2M
VERV
15
DELISTED
Verve Therapeutics
VERV
$28.2M 1.46%
600,000
-193,265
-24% -$9.08M
VECT
16
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$27.2M 1.41%
3,522,019
– –
SPRB
17
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$27.1M 1.4%
4,514,336
– –
OKUR
18
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$25.6M 1.32%
3,430,377
– –
FOLD icon
19
Amicus Therapeutics
FOLD
$2.34B
$24.5M 1.26%
2,560,211
+562,331
+28% +$5.37M
IOVA icon
20
Iovance Biotherapeutics
IOVA
$807M
$20.6M 1.07%
836,518
+161,358
+24% +$3.98M
BPMC
21
DELISTED
Blueprint Medicines
BPMC
$20.3M 1.05%
197,000
– –
GRTX
22
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$19.9M 1.03%
2,459,021
– –
LVTX icon
23
LAVA Therapeutics
LVTX
$41.3M
$19.7M 1.02%
3,327,312
– –
INSM icon
24
Insmed
INSM
$28.8B
$19.2M 0.99%
695,840
– –
SPNE
25
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$17.3M 0.89%
1,099,478
-14,368
-1% -$226K
1
2 3